Company intelligence / Profile preview

Former BioD

Cordova, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

BioD is a regenerative medicine company that develops, manufactures, and commercializes novel biologic products derived from placental tissues. The company's product portfolio is designed to enhance wound healing and tissue repair across various clinical applications, including orthopedics, wound care, and ophthalmology. BioD utilizes proprietary processing technologies to preserve the natural properties of the amniotic membrane and fluid. In 2016, the company was acquired by Derma Sciences, which was subsequently acquired by Integra LifeSciences, where BioD's technologies continue to be marketed.

Therapeutic areas: OtherCardiovascularEndocrinologyDermatologyOphthalmology
Modalities: BiologicCell therapyTissue engineering
Industry: Biotech

Beyond the preview

Go deeper on Former BioD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Former BioD.

Explore the full profile